Slater Technology Fund to invest in Alcinous Pharmaceuticals

PROVIDENCE – The Slater Technology Fund, along with private angel investors, will invest up to $600,000 in Alcinous Pharmaceuticals, the nonprofit seed fund announced on May 12. University of Rhode Island graduate students Nicholas DaSilva, Kenneth Rose and Benjamin Barlock started Alcinous at URI’s College of Pharmacy in 2017. The company is focused on development…

You must be a paid subscriber to read this content. To keep reading and receive unlimited access subscribe today for only $1.
Subscribe Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display